Welcome
Support Centre
04 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of intracranial pressure (ICP) (www.RESCUEicp.com)
ISRCTN ISRCTN66202560
ClinicalTrials.gov identifier
Public title Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of intracranial pressure (ICP) (www.RESCUEicp.com)
Scientific title An international prospective multi-centre randomised controlled trial comparing the efficacy of decompressive craniectomy versus optimal medical management for the treatment of refractory intracranial hypertension following brain trauma (www.RESCUEicp.com)
Acronym RESCUEicp Trial
Serial number at source N/A
Study hypothesis The application of decompressive craniectomy to head-injured patients with raised intracranial pressure (ICP) refractory to medical treatment results in improvement in outcome:
1. Decompressive craniectomy results in an improvement in the Extended Glasgow Outcome Score compared to optimal medical treatment
2. Decompressive craniectomy results in an improvement in surrogate endpoint measures (including specific outcome measures [36-item Short Form questionnaire], control of ICP, time in intensive care and time to discharge from the neurosurgical unit) compared to optimal medical treatment
Lay summary
Ethics approval Added 06/02/2009: Eastern MREC gave approval on the 22nd October 2003 (ref: 03/5/059)
Study design Randomised controlled trial
Countries of recruitment Canada, China, Czech Republic, Germany, Greece, Italy, Latvia, Malaysia, Russian Federation, Saudi Arabia, Singapore, Spain, Turkey, United Kingdom, United States of America
Disease/condition/study domain Severe traumatic brain injury
Participants - inclusion criteria 1. Patients aged 10 - 65 years, either sex
2. An abnormal computed tomography (CT) scan of the head
3. Requiring ICP monitoring with raised ICP (greater than 25 mmHg greater than 1 - 12 hours), refractory to initial medical measures
4. Patients may have an immediate operation for a mass lesion but not a decompressive craniectomy
5. Patients who are immunologically, hepatically or renally compromised can be included, but type and extent of their impairment are noted
Participants - exclusion criteria 1. Bilateral fixed and dilated pupils
2. Bleeding diathesis
3. A devastating injury not expected to survive for 24 hours
4. Follow-up not possible
5. Unable to monitor ICP
6. Patients treated on the Lund protocol
7. Primary decompression
8. Have received barbiturates pre-randomisation
9. Brainstem involvement
Anticipated start date 01/01/2004
Anticipated end date 01/01/2010
Status of trial Completed
Patient information material Information leaflet for relatives of patients at: http://www.rescueicp.com/Information%20sheet.pdf
Target number of participants 200 + 200 (400 total)
Interventions Decompressive craniectomy (surgical procedure) versus maximal medical management (including barbiturates).
Primary outcome measure(s) The primary endpoint will be assessment of outcome at discharge (Glasgow Outcome Score) and 6 months (Extended Glasgow Outcome Score).
Secondary outcome measure(s) Secondary endpoints will be:
1. Assessment of outcome using the 36-item short form (SF-36) questionnaire
2. Assessment of ICP control
3. Time in intensive care
4. Time to discharge from the neurosurgical unit
Sources of funding 1. Academy of Medical Sciences (UK)
2. The Health Foundation (UK)
Trial website http://www.RESCUEicp.com
Publications 2005 editorial in http://www.ncbi.nlm.nih.gov/pubmed/15614466
Contact name Mr  Peter  Hutchinson
  Address Box 167
Academic Neurosurgery Unit
Addenbrooke's Hospital
  City/town Cambridge
  Zip/Postcode CB2 2QQ
  Country United Kingdom
  Tel +44 (0)1223 336946
  Fax +44 (0)1223 216926
  Email pjah2@cam.ac.uk
Sponsor Addenbrooke's Hospital (UK)
  Address Dr Claudia Rizzini
R&D Office
Box 146
Addenbrooke's Hospital
  City/town Cambridge
  Zip/Postcode CB2 2QQ
  Country United Kingdom
  Tel +44 (0)1223 274 486
  Email rdenquiries@addenbrookes.nhs.uk
  Sponsor website: http://www.addenbrookes.nhs.uk/research/rd_office.html
Date applied 12/09/2005
Last edited 09/02/2009
Date ISRCTN assigned 21/11/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central